Cover Image

A comparative diagnostic study using clinical and multimodal assessment, including functional neuroimaging and oculomotricity tools, to differentiate ADHD in young patients from healthy control group

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Guocan Ma, Alexander E. Eng, Soon‐kiat Chiang, Fengyi Hao, Roger S. McIntyre, Dewen Zhou, Ying Yang, Roger C. Ho, Kai Chi Yam
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Psychiatry and Clinical Neurosciences
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations
by: Kengo Yonezawa, et al.
Published: (2026)

Transdiagnostic approach for neuropsychiatric symptoms using neuroimage
by: Shinsuke Koike
Published: (2025)

Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review
by: Yasmin Esmaeilian, et al.
Published: (2026)

Dimensional association between ADHD traits and gray matter volume in young adults: A voxel‐based morphometry study
by: Haruka Asaoka, et al.
Published: (2026)

Serotonergic underpinnings of obsessive‐compulsive disorder: A systematic review and meta‐analysis of neuroimaging findings
by: Martin Pastre, et al.
Published: (2024)

Neuropsychiatric symptoms and neuroimaging‐based brain age in mild cognitive impairment and early dementia: A multicenter study
by: Daichi Sone, et al.
Published: (2025)

[18F]FE‐PE2I PET is a diagnostic tool in dementia with Lewy bodies
by: Andrea Sturchio, et al.
Published: (2025)

Editorial: Deciphering dopamine dysregulation in adult ADHD
by: Norio Yasui‐Furukori
Published: (2025)

Associations between attenuated auditory p300 event‐related potential and cognitive basic symptoms in young people at clinical high risk for psychosis
by: James C. Martin, et al.
Published: (2025)

Re‐evaluating age‐related attention‐deficit/hyperactivity disorder (ADHD) symptom trajectories using the Japanese ADHD Rating Scale‐5
by: Ryotaro Shimomura, et al.
Published: (2026)

Internet gaming disorder symptoms and functional impairment in a non‐clinical sample of adolescents and young adults in Japan
by: Masaru Tateno, et al.
Published: (2026)

Catatonia and elevated mortality: A population‐wide cohort study with healthy, sibling, and schizophrenia spectrum controls
by: Chih‐Wei Hsu, et al.
Published: (2025)

Inter‐rater reliability study of the Japanese version of the diagnostic clinical interview for drug withdrawal post SSRIs or SNRIs (DID‐W1‐J)
by: Tomoyuki Nakamura, et al.
Published: (2025)

Differential working memory changes following methylphenidate in medication‐naive and medication‐experienced adults with ADHD
by: Masaaki Shimizu, et al.
Published: (2026)

Brexpiprazole‐related tardive dystonia in a young patient with schizophrenia: A case report
by: Takumi Ebina, et al.
Published: (2024)

ADHD medications and drug withdrawal: A pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database
by: Takumi Ebina, et al.
Published: (2026)

Cognitive profile of psychiatric patients with coexisting enlarged ventricles and cognitive impairment: A rare cross‐diagnostic phenotype predominantly observed in schizophrenia
by: Junya Matsumoto, et al.
Published: (2025)

Effectiveness of the Early Start Denver Model (ESDM) as an early intervention for young children with autism spectrum disorder in clinical settings in Japan: A non‐randomized controlled trial
by: Yukie Tateno, et al.
Published: (2026)

Tetrabenazine‐induced acute dystonic reaction during the treatment of comorbid tics in a young woman with autism spectrum disorder
by: Marcelo D. Mendonça, et al.
Published: (2024)

Trick or treat? It's time to rethink the role of placebo in clinical trial
by: Ping‐Tao Tseng, et al.
Published: (2024)

Impact of a mindfulness‐based intervention on neurobehavioral functioning and its association with large‐scale brain networks in preterm young adolescents
by: Vanessa Siffredi, et al.
Published: (2024)

When is an MRI‐based classification first ready for use in clinical settings?
by: Shinsuke Koike
Published: (2024)

Severe self‐limiting acute bilateral hearing loss following a low dose of methylphenidate for ADHD treatment: A case report
by: Atefeh Zandifar, et al.
Published: (2026)

Genetics of bipolar disorder: Translating discoveries to biological insights and clinical decision support
by: Guy Hindley, et al.
Published: (2026)

Association between serum cytokines and timeframe for conversion from clinical high‐risk to psychosis
by: TianHong Zhang, et al.
Published: (2024)

Advancing treatment response prediction in first‐episode psychosis: integrating clinical and electroencephalography features
by: Livia Dominicus, et al.
Published: (2025)

Sleep and circadian disruption in bipolar disorders: From psychopathology to digital phenotyping in clinical practice
by: André C. Tonon, et al.
Published: (2024)

Barriers to evidence‐based psychotherapy implementation: An international survey of workload, training, and clinical practice
by: Naoki Takamatsu, et al.
Published: (2026)

Noninvasive intervention by transcranial ultrasound stimulation: Modulation of neural circuits and its clinical perspectives
by: Takahiro Osada, et al.
Published: (2024)

REIMAGINE: A central nervous system basket trial showing safety and efficacy of vafidemstat on aggression in different psychiatric disorders
by: Marc Ferrer, et al.
Published: (2025)

Normative brain variability, clinical dimension, and molecular‐transcriptomic correlates of bipolar risk in depressed patients
by: Junneng Shao, et al.
Published: (2026)

Distinct delay discounting patterns in anorexia nervosa: Comparing monetary and exercise rewards across clinical subgroups
by: Paolo Meneguzzo, et al.
Published: (2025)

Why high‐performing psychiatric machine learning models often fail in real‐world clinical settings?
by: Thiago P. Fernandes, et al.
Published: (2026)

AST‐001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial
by: Hyo‐Won Kim, et al.
Published: (2024)

The development of positron emission tomography ( PET ) tracer for glutamate AMPA receptors and its application to human biology and clinics
by: Mai Hatano, et al.
Published: (2026)

Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate
by: Chieh‐Hsin Lin, et al.
Published: (2025)

Flunitrazepam increases the risk of lamotrigine‐induced cutaneous adverse reactions: Combined analysis of medical big data and clinical research
by: Hiroshi Bando, et al.
Published: (2025)

Correction to “ AST ‐001 versus placebo for social communication in children with autism spectrum disorder: A randomized clinical trial”
Published: (2025)

Comparing the performance of ChatGPT GPT‐4, Bard, and Llama‐2 in the Taiwan Psychiatric Licensing Examination and in differential diagnosis with multi‐center psychiatrists
by: Dian‐Jeng Li, et al.
Published: (2024)

Long‐acting antipsychotics and mortality in patients with schizophrenia receiving homecare case management
by: Wen‐Yin Chen, et al.
Published: (2025)